Palatin Technologies Inc.

07/15/2025 | Press release | Distributed by Public on 07/15/2025 05:45

Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Palatin Technologies Inc. published this content on July 15, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 15, 2025 at 11:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io